Yuriko Abe

Dr. Yuriko Abe


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
RTRyousuke Tonouchi
Ryousuke Tonouchi
TOTomoo Okada
Tomoo Okada
YAYuriko Abe
Yuriko Abe
MKMinako Kazama
Minako Kazama
YKYuki Kuromori
Yuki Kuromori
IMIchiro Morioka
Ichiro Morioka

21 October 2022 in Children
Verified
Journal Article
Open access
PDF file
MAMamoru Ayusawa
Mamoru Ayusawa
HNHidemasa Namiki
Hidemasa Namiki
YAYuriko Abe
Yuriko Abe
RIRie Ichikawa
Rie Ichikawa
IMIchiro Morioka
Ichiro Morioka
We investigated the incidence of sudden death in students with a history of Kawasaki disease (KD) while under school supervision. Reports of sudden death in students with a history of KD during 1990–1999 and 2000–2009 were retrieved from the mutual aid system data. The student’s grade, sex, circumstances at the time of sudden death, final diagnosis, recommended restrictions on school activities, and intensity of physical activity at the time of sudden death were investigated. There were 11 cases from 1990 to 1999 and 3 from 2000 to 2009; KD was complicated with coronary artery aneurysm (CAA) in nine and one cases, respectively. The incidence of sudden death decreased by approximately 50% for KD history and 80% for KD with CAA between the two decades; however, the difference was not statistically significant. Of the 14 cases, 12 occurred during moderate-to-strenuous exercise; the restriction on exercise for students with KD complicated with CAA was not followed in at least five cases during 1990–1999, while three cases during 2000–2009 occurred without recommended restriction. Cases of sudden cardiac death decreased during 2000–2009, compared with those during 1990–1999. Special attention is required for students with a history of KD, particularly when complicated with CAA.

Verified
Journal Article
Open access
PDF file
YAYuriko Abe
Yuriko Abe
RTRyousuke Tonouchi
Ryousuke Tonouchi
MHMitsuhiko Hara
Mitsuhiko Hara
TOTomoo Okada
Tomoo Okada
EJEric Hajime Jego
Eric Hajime Jego
IMIchiro Morioka
Ichiro Morioka
Abdominal bioelectrical impedance analysis (aBIA) has been in use to measure visceral fat area (VFA) in adults. Accurately measuring visceral fat using aBIA in children is challenging. Forty-six school-aged Japanese children aged 6–17 years (25 boys and 21 girls) were included in this study. All were measured, and their VFA obtained using aBIA (VFA-aBIA) and abdominal computed tomography (CT) (VFA-CT) were compared. VFA-aBIA was corrected using the Passing–Bablok method (corrected VFA-aBIA). The relationships between corrected VFA-aBIA and obesity-related clinical factors were analyzed, including non-alcoholic fatty liver disease (NAFLD) and serum leptin and adiponectin levels. Boys had higher VFA-CT than girls (p = 0.042), although no significant differences were found in their waist circumference, waist-to-height ratio, and body mass index. The corrected VFA-aBIA using y = 9.600 + 0.3825x (boys) and y = 7.607 + 0.3661x (girls) correlated with VFA-CT in both boys and girls. The corrected VFA-aBIA in patients with NAFLD was higher than that in those without NAFLD. Serum leptin and adiponectin levels were positively and negatively correlated with corrected VFA-aBIA, respectively. In conclusion, corrected VFA-aBIA was clearly correlated with VFA-CT and was related to NAFLD and serum leptin and adiponectin levels in school-aged Japanese children.

22 December 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
YAYuriko Abe
Yuriko Abe
CKChika Kusano
Chika Kusano
CTChika Takano
Chika Takano
IMIchiro Morioka
Ichiro Morioka
TGTakuji Gotoda
Takuji Gotoda

Verified
Journal Article
Open access
PDF file
HYHiromi Yamaguchi
Hiromi Yamaguchi
Ramiro José González-DuarteRamiro José González-Duarte
Ramiro José González-Duarte
Xian-Yang QinXian-Yang Qin
Xian-Yang Qin
YAYuriko Abe
Yuriko Abe
ITIchiro Takada
Ichiro Takada
MEMariko Esumi
Mariko Esumi
Transglutaminase 2 (TG2) is a multifunctional protein and plays a role in cancer progression. We previously identified TG2 as an early-recurrence biomarker in hepatocellular carcinoma (HCC). TG2-knockdown (shTG2) and control (shCtl) HCC cell lines were used for comparative analyses to clarify the molecular mechanisms underlying the contribution of this protein to HCC malignancy. The proliferation of shTG2 cells was slightly but significantly decreased compared with that of shCtl cells. Differential gene expression profiling based on GeneChip arrays revealed the enrichment of the PI3K-Akt signaling pathway and showed that the expression of Dickkopf-1 and -3 (DKK1 and DKK3, respectively), inhibitors and modulators of the Wnt/β-catenin signaling pathway, was increased in shTG2 cells. The expression of epithelial–mesenchymal transition (EMT)-related genes was similar in both shCtl and shTG2 cells before and after TGF-β1 treatment, even though TGF-β1 markedly upregulated TG2. Thus, TG2 may contribute to cancer malignancy via the stimulation of cell proliferation signaling, such as PI3K-Akt and Wnt/β-catenin signaling, but not EMT. This effect might be further enhanced by humoral factors such as TGF-β1 from the tumor microenvironment.